FindTrial
Sign In

The role of cortistatin in psoriasis vulgaris

Cortistatin is dysregulated in the skin tissues of patients with psoriasis vulgaris and suppresses the proliferative activities of keratinocytes in vitro

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CCC-12002526
Enrollment
Unknown
Registered
2012-09-18
Start date
2009-01-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

Control group:none
Psoriasis group:none

Sponsors

Xiangya hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 62 Years

Inclusion criteria

Inclusion criteria: Psoriasis vugaris diagnosised by clinical symptom and pathematology;Healthy subjects determined by medical examination.

Exclusion criteria

Exclusion criteria: psoriasis patients with other disease; Control subjects with their any index is abnormal; Patients or healthy without self-perceived other body discomforts

Design outcomes

Primary

MeasureTime frame
The concentration of cortistatin in plasma;The expression of skin cortistatin;—

Countries

China

Contacts

Public ContactDai Li
lidaimail@yahoo.com.cn+86 13975806485

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026